Secondary adrenal insufficiency due to isolated acth deficiency induced by pembrolizumab: a report of twocases of uterine endometrial cancer

HIGHLIGHTS

• who: Ichiro Onoyama and collaborators from the Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan have published the research work: Secondary Adrenal Insufficiency Due to Isolated ACTH Deficiency Induced by Pembrolizumab: A Report of TwoCases of Uterine Endometrial Cancer, in the Journal: Reports 2023, 6, 18. of 17/04/2023
• what: The authors report two cases of secondary adrenal insufficiency during treatment of endometrial cancer with pembrolizumab.

SUMMARY

Immune checkpoint inhibitors (ICIs) enhance antitumoral immune mechanisms and are used to treat certain cancer . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.